In the first large, controlled study of Bayer AG’s sterility device Essure, researchers found that women who have had it implanted were 10 times as likely to need new operations as women who got standard sterility surgery.
Women have spoken of debilitating pain and allergic reactions to the Essure implants, including at a Food and Drug Administration workshop last month. Some 750,000 or more women world-wide have gotten the Essure implants, but it has been difficult to assess the scope of the problem until this study.
Help employers find you! Check out all the jobs and post your resume.
